Bakx Therapeutics, Inc.
Biotechnology company · Bearsville, New York, United States
Bakx Therapeutics, Inc. is a biotechnology company headquartered in Bearsville, New York, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2021.
Bakx Therapeutics at a glance
What does Bakx Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $20.3 million sold (2021).
Frequently asked questions about Bakx Therapeutics
Where is Bakx Therapeutics headquartered?
Bakx Therapeutics, Inc. is headquartered in Bearsville, New York, United States.
What does Bakx Therapeutics do?
Bakx Therapeutics, Inc. is a biotechnology company.
When was Bakx Therapeutics founded?
The earliest incorporation on record for Bakx Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences